Australian Cannabis Companies – top 20
|

Australian Cannabis Companies – top 20

Australian Cannabis Companies 2022 – top 20 list Whether it’s a “gold rush” to secure registration for selling over-the-counter at chemists, proactive outreach to get clinicians on side, or pocket-emptying, long-game research requiring patience and patients at a pharmaceutical level, medicinal cannabis is an industry that attracts all stripes. Against the backdrop of a global…

ECS delivers 450% PCP growth in Q3 revenue, targets UK and European giants as new frontiers for its homegrown cannabis

ECS delivers 450% PCP growth in Q3 revenue, targets UK and European giants as new frontiers for its homegrown cannabis

ECS Botanics has had another incredibly productive quarter, producing revenue of over $2m in Q3. And with the European majors opening up, the vertically integrated company says it’s in a great position with harvesting currently underway. Benchmark Aussie medicinal cannabis play ECS Botanics (ASX:ECS) has delivered more than $2million in revenue for the third quarter, as demand…

‘Our first cannabis crops failed, but we learned along the way’

‘Our first cannabis crops failed, but we learned along the way’

Having a regulatory compliance expert for a husband may have kick-started her cannabis career, but Nan-Maree Schoerie is ploughing her own path in the industry. In the first of a two-part interview with Cannabiz, she tells of the early days of Murray Meds and explains why greenhouse growing is no longer sustainable in Australia. Sometimes in…

ECS Botanics will supply cannabis biomass to Sun Pharma to produce resin under a 10-year deal
|

ECS Botanics inks cannabis supply and tolling deal with Sun Pharma

Medicinal cannabis and hemp company ECS Botanics Holdings (ASX: ECS) has revealed it has entered into a collaborative supply and toll processing agreement for cannabis biomass extraction with pharmaceutical company Sun Pharma. Sun Pharma is an Australia-based subsidiary of Sun Pharmaceutical Industries, the fourth largest specialty generic pharmaceutical company in the world. With global revenues in excess…

Germany: Likely future government supports cannabis legalisation

Germany: Likely future government supports cannabis legalisation

The country’s next coalition government plans to keep cannabis tightly regulated, party representatives said. Recreational use of cannabis is only legal in two other EU countries. Germany’s future coalition of the Social Democrats (SPD), Green party, and Free Democrats (FDP), have signalled that they are seriously considering legalizing the possession of cannabis. Representatives from the parties told…

Alex Keach “I GREW UP WITH POPPY FIELDS ALL AROUND ME. SO, WHY NOT CANNABIS?”

Alex Keach “I GREW UP WITH POPPY FIELDS ALL AROUND ME. SO, WHY NOT CANNABIS?”

Australian cannabis companies are standing out as making a cautious yet steady entry into the cannabis industry. One of these companies is ECS Botanics. “ECS Botanics started as a hemp company,” says Alex Keach, founder, and Managing Director of ECS Botanics. “We have a farm in Tasmania where we grow our cannabis outdoors.” The idea…

Cannabidiol: The ultimate investor’s guide to a potential $64 billion global market

Cannabidiol: The ultimate investor’s guide to a potential $64 billion global market

Cannabis has been used as medicine for thousands of years. Ancient Indian, Chinese, and Egyptian civilisations have all employed it to cure various illnesses. But increasing recreational use and perceived harm to society meant that it has been outlawed in many countries since the early 20th century. In the US for example, cannabis was restricted…

Canngea attracted to ECS Botanics’ sustainably grown cannabis, inks deal

Canngea attracted to ECS Botanics’ sustainably grown cannabis, inks deal

The company flagged additional revenue opportunities in the year ahead as it establishes traction as the leading B2B supplier in the Australian cannabis market as the supply agreement with Canngea finalised. Leading medicinal cannabis company ECS Botanics (ASX:ECS) continues to execute on a rapid growth trajectory, as it gains traction as the supplier of choice for a…

ECS Botanics Managing Director Message: Why Australia for Medicinal Cannabis

ECS Botanics Managing Director Message: Why Australia for Medicinal Cannabis

Dear shareholders, FY21 has been a defining year for the company as we start to leverage assets that we have established in proceeding years. These include our production base, industry leading team and culture, intellectual property and systems. As a result, the company is at a major inflection point. We are now in a position…

Murray Meds Facility (ECS Subsidiary)

Lean, mean and green: ECS Botanics, holds medicinal cannabis licenses and GMP standards to execute on a global market opportunity

Managing Director, Alex Keach breaks down the demand dynamics for medicinal cannabis & GMP complaint products, as ECS Botanics Holdings looks to execute on a global market opportunity. After a multi-year period of development, the pieces are now in place for Australia to become a global leader in the production, sale and export of medicinal cannabis, ECS Botanics’ Managing…

Industrial Hemp crops suited to warmer climate

Industrial Hemp crops suited to warmer climate

The Northern Territory is exploring whether its warm winter weather could deliver an edge in Australia’s emerging industrial hemp market. Industrial hemp is an environmentally sustainable crop that can be used in thousands of products including building materials, textiles and beer. NT growers could be well-positioned to produce dry season fibre crops to supply southern…

ECS Botanics jumps almost 5pc on $4.5 million Polish deal

ECS Botanics jumps almost 5pc on $4.5 million Polish deal

ECS Botanics Holdings has secured a 5-year $4.5 million deal to supply Polish company Alivio Spolka with the GMP manufactured Medicinal Cannabis. Shares in ECS Botanics Holdings (ASX:ECS) have jumped almost 5% today after the company announced it secured a five-year agreement with Polish company Alivio Spolka for the supply of $4.5 million worth of GMP manufactured…